Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay.
The characteristics are described of an antibody (designated L6) which has virtually absolute specificity for heptadecapeptide gastrin. This antibody binds G17, but does not bind peptide fragments or molecular forms of gastrin comprising G17 with either amino acid deletions, or additions, at the carboxyl- and amino-terminals. In serum from patients with Zollinger-Ellison syndrome the only form of gastrin revealed by L6 was compatible with G17, and there was good agreement between estimated G17 concentrations in serum analyzed by gel filtration and by direct radioimmunoassay using L6. Using L6 in conjunction with antibodies specific for carboxyl- and amino-terminals of G17 it has been possible to measure concentrations of different forms of gastrin in serum of normal subjects after a meal in greater detail than previously possible. After a light meal consisting of eggs, toast, and Oxo, serum concentrations of G17 measured by L6 increased to a peak 20 min after feeding (delta gastrin, 19 pmoles per liter; n = 17). In contrast, concentration of G34 peaked at 50 min (delta gastrin, 27 pmoles per liter). Small amounts of amino-terminal fragments of G17 were present throughout the digestive period. Applying the known ratio of biological potencies of G34 and G17 for stimulation of acid secretion in man, it is estimated that G17 accounts for about 75% of the biological activity in blood after a meal, even though G34 is present in higher molar concentrations.
D000293:Adolescent; D000328:Adult; D000906:Antibodies; D000918:Antibody Specificity; D002850:Chromatography, Gel; D004435:Eating; D005215:Fasting; D005260:Female; D005755:Gastrins / Q000097:blood* / Q000276:immunology; D006801:Humans; D008297:Male; D010455:Peptides / Q000097:blood*; D011863:Radioimmunoassay / Q000379:methods*; D015043:Zollinger-Ellison Syndrome / Q000097:blood / Q000276:immunology
D000906:Antibodies; D005755:Gastrins; D010455:Peptides